期刊文献+

异基因骨髓间充质干细胞移植对胶原诱导性关节炎大鼠的免疫调节作用 被引量:4

The immunomodulatory effect of allogenic mesenchymal stem cell transplantation on rats with coll- agen induced arthritis
原文传递
导出
摘要 目的 通过对类风湿关节炎(RA)动物模型胶原诱导性关节炎(CIA)大鼠的实验研究,观察异基因骨髓间充质干细胞(MSCs)移植对早期、晚期CIA大鼠免疫细胞和分子的免疫学作用,并探讨其在体内发挥免疫调节作用的机制.方法 采用密度梯度离心结合贴壁培养法体外分离、培养大鼠MSCs,细胞表型鉴定;建立CIA大鼠模型;MSCs移植均采用尾静脉注射,移植后第42天全部处死动物取脾,通过实时定量-聚合酶链反应(RT-PCR)测定Foxp3 mRNA的表达水平,流式细胞术测定CD4+CD25+调节性T细胞的变化.采用单因素方差分析、LSD-t检验法进行统计学分析.结果 早期、晚期CIA对照组CD4+CD25+调节性T细胞(1.6±0.6,1.4±0.6)和Foxp3 mRNA(0.88±0.20,0.91±0.12)的表达水平低于健康组和治疗组,差异有统计学意义(P<0.05),早期治疗组CD4+CD25+调节性T细胞(5.0±0.4)比晚期治疗组(3.9±0.4)有所升高,差异有统计学意义(P<0.05).结论 异基因MSCs移植可通过上调CIA大鼠体内CD4+CD25+调节性T细胞水平,促进Foxp3 mRNA的表达而发挥其在体内的免疫调节作用,早期治疗组的疗效优于晚期治疗组. Objective To observe the immunologic effect of transplantation of MSCs by studying the early and later period of collagen induced arthritis. Methods Rats MSCs were isolated and expanded from bone marrow cells by density gradient centrifugation and adhering to the culture plastic bottle, and the phenotypes were assessed by flow cytometry. We established collagen induced arthritis rats model. MSCs wereinjected from tail veins. We observed the expression of Foxp3 mRNA using RT-PCR, and the level of CD4+CD25+ T cell was tested by flow cytometry. One-way ANOVA and LSD-t test were used for statistical analysis.Results The percentage of CD4+ CD25+ T cells in early and later CIA groups was lower than that of normal control group and treatment groups, which showed statistically significant difference (P〈0.05). The level of CD4+ CD25+ T cell in early MSCs treatment group was higher than the later MSNs treatment group, which showed statistically significant difference (P〈0.05). Compared to the normal group and treatment groups, the expression level of Foxp3 mRNA in the early and later CIA groups was decreased markedly, while the early MSNs treatment group versus the later treatment group showed no statistically significant difference (P〉0.05).The intensity of Foxp3 mRNA in the treatment groups was similar to normal control group. Conclusion In this study, MSCs has shown significant immune-modulatory effects. It up-regulates the level of CD4+ CD25+ T cell in CIA rats, accelerate the expression of Foxp3 mRNA. The early treatment group is more effective than the late treatment group.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2010年第10期682-685,共4页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 关节炎 实验性 间质干细胞 Arthritis, rheumatoid Arthritis, experimental Mesenchymal stem cell
  • 相关文献

参考文献25

  • 1T(o)gel F,Hu Z,Weiss K,et al.Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.Am J Physiol RenalPhvsiol,2005,289:F31-42.
  • 2Trentham DE,Townes AS,Kang AH.Autoimmunity to type Ⅱcollagen an experimental model of arthritis.J Exp Med,1977,146:857-868.
  • 3Courtenay JS,Dallman M J,Dayan AD,et al.Immunization against heterologous type Ⅱ collagen induced arthritis in mice.Nature,1980,283:666-668.
  • 4Myers LK,Rosloniec EF,Cremer MA,et al.Collagen-induced arthritis,an animal model of autoimmunity.Life Sci,1997,61:1861-1878.
  • 5Brand DD,Kang AH,Rosloniec EF.The mouse model of collagen-induced arthritis.Methods Mol Med,2004,102:295-312.
  • 6Brahn E,Peacock DJ,Banquerigo ML.Suppression of collageninduced arthritis by combination cyclosporin A and methotrexate therapy.Arthritis Rheum,1991,34:1282-1288.
  • 7Schett G,Middleton S,Bolon B,et al.Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.Arthritis Rheum,2005,52:1604-1611.
  • 8Bakharevski O,Stein-Oakley AN,Thomson NM,et al.Collagen induced arthritis in rats:contrasting effect of subcutaneous versus intradermal inoculation of type Ⅱ collagen.J Rheumatol,1998,25:1945-1952.
  • 9Morgan ME,Flierman R,van Duivenvoorde LM,et al.Effective treatment of collagen-induced arthritis by adaptive transfer of CD25+ regulatory T cells.Arthritis Rheum,2005,52:2212-2221.
  • 10Barry FP.Mesenchymal stem cell therapy in joint disease.Novartis Found Symp,2003,249:86-96.

二级参考文献15

  • 1Weyand C M.New insights into the pathogenesis of rheumatoid arthritis[J].Rheumatology,2000;39(Suppl 1):3-8.
  • 2Hori S,Sakaguchi S.Foxp3:a critical regulator of the development and function of regulatory T cells[J].Microbes and Infection,2004;6(8):745-751.
  • 3Amelsfort J M,Jacobs K M,Bijlsma J W et al.CD4+CD25+ regulatory T cells in rheumatoid arthritis[J].Arthritis Rheum,2004;50(9):2775-2785.
  • 4Cao D,Vollenhoven R,Klareskog L et al.CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease[J].Arthritis Res Ther,2004;6:R335-R346.
  • 5Prevoo M L,Vant'Hof M A,Kuper H H et al.Modified disease activity scores that include twenty-eight-joint counts.Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[J].Arthritis Rheum,1995;38(1):315-324.
  • 6Sakaguchi S.The origin of Foxp3-expressing CD4+ regulatory T cells:thymus or periphery[J].J Clin Invest,2003;112(9):1310-1322.
  • 7Fontenot J D,Rasmussen J P,Williams L M et al.Regulatory T cell lineage specification by the forkhead transcription factor Foxp3[J].Immunity,2005;22(3):329-341.
  • 8Hori S,Nornura T,Sakaguchi S et al.Control of regulatory T cell development by the transcription factor Foxp3[J].Science,2003;299(5609):1057-1061.
  • 9Kleer I M,Wedderburn L R,Taams L S et al.CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis[J].J Immunol,2004;172(10):6435-6443.
  • 10Karube K,Ohshima K,Takeshi T et al.Expression of Foxp3,a key molecule in CD4+CD25+ regulatory T cells,in adult T-cell leukaemia/lymphoma cells[J].Br J Haematol,2004;126(1):81-84.

共引文献22

同被引文献39

  • 1刘喜德,万力生.类风湿关节炎的诊断与治疗.北京:人民军医出版社.2006.
  • 2Abramson SB, Amin A. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology, 2002, 41 : 972-980.
  • 3Szekanecz Z, Haines GK, Har LA, et al. Increased synovia 1 expression of trans-forming growth factor (TGF)-βreceptor endoglin and TGF-βin rhe -umatoid arthritis possible interaction in the pathogenesis of the diesease. Clin Immunol Immunopatbol, 1995, 7: 187.
  • 4Vuolteenaho K, Moilanen T, Hamalainen M, et al. Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage, role of endegonous IL-1 inhibitors. Scand J Rheumatol, 2003, 32: 19-24.
  • 5Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NF kappaB ligand and tumor necrosis factor alpha in bone destruction. Bone, 2002, 30: 340-346.
  • 6Ozaki K, Sato K, Oh I, et al. Mechanisms of immunomodulation by mesenchymal stem cells. Int Hematol, 2007, 86: 5-7.
  • 7Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood, 2007, 110: 3499-3506.
  • 8Schwartz RH. Tcell anergy. Ann Rev Immunol, 2003, 21: 305- 334.
  • 9Chen X, Armstrong MA, Li G. Mesenchymal stem cells in immunoregulation. Immunol Cell Biol, 2006, 84: 413-421.
  • 10Liu Y,Mu R,Wang S, et al.Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis [J]. 2010, 12(6):R210.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部